Track and trace growth and differentiation of hundreds of iPSC-derived organoids.
Adoption of iPSC-derived organoids has been limited to relatively low throughput applications, as the workflows are hampered by challenges in reproducibility and scalability, as well as being manually intensive.
Reimagine your iPSC-derived organoid assays
With the CellRaft Technology, we have shown how to increase the generation and reproducibility of iPSC-derived organoids.
Take a look at the newly released application note to answer the following questions:
Relevant for your research? Download the App Note to improve your research pursuits:
Making the impossible possible: Platform and protocols to develop clonal iPSC-derived organoidsDownload Here
Dr. Thorsten Rieling